[{"quiz_id": "20251225T204141396Z_grok-4-0709_seed132", "question_id": "20251225T204141396Z_grok-4-0709_seed132-001", "question": "A 45-year-old man presents with progressive bilateral leg weakness, urinary incontinence, and episodic vertigo over 6 months. Examination reveals spastic paraparesis, upbeat nystagmus, and a positive Romberg sign. MRI shows T2 hyperintensities in the cerebellar peduncles and periventricular white matter. CSF analysis is normal except for elevated IgG index. What is the most likely diagnosis?", "options": ["Primary progressive multiple sclerosis", "Susac syndrome", "Behçet disease", "Neuromyelitis optica spectrum disorder", "Cerebrotendinous xanthomatosis"], "answer": "B", "answer_index": 1, "explanation": "Susac syndrome is characterized by the triad of encephalopathy, branch retinal artery occlusions, and sensorineural hearing loss, but can present with cerebellar involvement and white matter lesions mimicking multiple sclerosis. Primary progressive multiple sclerosis typically lacks the specific upbeat nystagmus and vertigo seen here, while Behçet disease often includes oral ulcers and uveitis, which are absent. Neuromyelitis optica spectrum disorder usually features optic neuritis or transverse myelitis with aquaporin-4 antibodies, not present in this case.", "generator_model": "grok-4-0709", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Neurology", "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: K (Miskeyed). Verdict on keyed answer: Miskeyed. The stem describes a 45-year-old man with progressive bilateral leg weakness, spastic paraparesis, upbeat nystagmus, positive Romberg, and MRI T2 hyperintensities in cerebellar peduncles and periventricular white matter, with elevated CSF IgG index. The classic triad for Susac syndrome (encephalopathy, branch retinal artery occlusions, sensorineural hearing loss) is absent. The findings are highly characteristic of primary progressive multiple sclerosis (PPMS), which commonly presents with progressive myelopathy (spastic paraparesis, urinary incontinence), cerebellar signs (vertigo, nystagmus), and typical MRI/CSF findings (elevated IgG index). PPMS is the single best answer. The keyed answer (B, Susac syndrome) is incorrect. Main logical issue: key mismatch. Main medical accuracy issue: the rationale incorrectly states PPMS typically lacks upbeat nystagmus and vertigo, which can occur in MS. Minimal fix: Change correct answer key to A.\", \"logical_false_reason\": \"K\", \"logical_validity\": false, \"medical_accuracy_score\": \t\"3\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict on keyed answer: Miskeyed. The stem describes a 45-year-old man with progressive bilateral leg weakness, spastic paraparesis, upbeat nystagmus, positive Romberg, and MRI T2 hyperintensities in cerebellar peduncles and periventricular white matter, with elevated CSF IgG index. The classic triad for Susac syndrome (encephalopathy, branch retinal artery occlusions, sensorineural hearing loss) is absent. The findings are highly characteristic of primary progressive multiple sclerosis (PPMS), which commonly presents with progressive myelopathy (spastic paraparesis, urinary incontinence), cerebellar signs (vertigo, nystagmus), and typical MRI/CSF findings (elevated IgG index). PPMS is the single best answer. The keyed answer (B, Susac syndrome) is incorrect. Main logical issue: key mismatch. Main medical accuracy issue: the rationale incorrectly states PPMS typically lacks upbeat nystagmus and vertigo, which can occur in MS. Minimal fix: Change correct answer key to A.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251225T204141396Z_grok-4-0709_seed132", "question_id": "20251225T204141396Z_grok-4-0709_seed132-002", "question": "A 32-year-old woman with a history of atopic dermatitis develops widespread pruritic vesicles and bullae after starting a new biologic therapy. Biopsy shows subepidermal clefting with eosinophils and flame figures. Direct immunofluorescence is negative. What is the most appropriate next step in management?", "options": ["Switch to dupilumab", "Initiate dapsone therapy", "Administer rituximab", "Prescribe high-dose systemic corticosteroids", "Perform patch testing for contact allergens"], "answer": "B", "answer_index": 1, "explanation": "This presentation suggests bullous pemphigoid-like eruption induced by biologic therapy, but the flame figures and eosinophilic spongiosis point to eosinophilic cellulitis (Wells syndrome), which responds well to dapsone. Switching to dupilumab might exacerbate atopic conditions without addressing the eosinophilic component, while rituximab is reserved for refractory autoimmune bullous diseases. Systemic corticosteroids could provide temporary relief but are not first-line for this entity.", "generator_model": "grok-4-0709", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Dermatology", "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: K (Miskeyed). Verdict on keyed answer: Miskeyed. Key stem clues: history of atopic dermatitis, new biologic therapy, widespread pruritic vesicles/bullae, biopsy showing subepidermal clefting with eosinophils and flame figures, negative direct immunofluorescence. The findings are classic for bullous pemphigoid (BP), especially drug-induced BP from biologics, where negative DIF can occur early. Flame figures are nonspecific and can be seen in BP. The most appropriate next step for suspected drug-induced BP is to stop the offending drug and initiate first-line treatment, which is high-potency topical corticosteroids or systemic corticosteroids for widespread disease. Dapsone is a second-line agent for BP, not first-line. Thus, option D is uniquely defensible as best. Main logical issue: Key B does not match the single best answer. Main medical accuracy issue: Dapsone is not first-line for widespread bullous pemphigoid; systemic corticosteroids are. Minimal fix: Change key to D, or adjust rationale to align with BP management guidelines.\",\n  \"medical_accuracy_score\":  \"2\",\n  \"logical_validity\": false,\n  \"logical_false_reason\": \"K\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict on keyed answer: Miskeyed. Key stem clues: history of atopic dermatitis, new biologic therapy, widespread pruritic vesicles/bullae, biopsy showing subepidermal clefting with eosinophils and flame figures, negative direct immunofluorescence. The findings are classic for bullous pemphigoid (BP), especially drug-induced BP from biologics, where negative DIF can occur early. Flame figures are nonspecific and can be seen in BP. The most appropriate next step for suspected drug-induced BP is to stop the offending drug and initiate first-line treatment, which is high-potency topical corticosteroids or systemic corticosteroids for widespread disease. Dapsone is a second-line agent for BP, not first-line. Thus, option D is uniquely defensible as best. Main logical issue: Key B does not match the single best answer. Main medical accuracy issue: Dapsone is not first-line for widespread bullous pemphigoid; systemic corticosteroids are. Minimal fix: Change key to D, or adjust rationale to align with BP management guidelines.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251225T204141396Z_grok-4-0709_seed132", "question_id": "20251225T204141396Z_grok-4-0709_seed132-003", "question": "A 58-year-old man with incomplete tetraplegia from a C5 spinal cord injury undergoes functional electrical stimulation therapy. After 3 months, he develops shoulder pain and limited abduction. Imaging reveals heterotopic ossification around the glenohumeral joint. What is the most effective intervention to preserve joint mobility?", "options": ["Bisphosphonate therapy", "Low-dose radiation", "Surgical excision", "Indomethacin prophylaxis", "Passive range-of-motion exercises"], "answer": "B", "answer_index": 1, "explanation": "Low-dose radiation therapy is highly effective in preventing maturation of heterotopic ossification in spinal cord injury patients, preserving joint function without systemic side effects. Bisphosphonates like etidronate can inhibit mineralization but are less targeted and may cause gastrointestinal issues. Surgical excision is considered only after ossification matures and if function is severely impaired, not as a primary intervention.", "generator_model": "grok-4-0709", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Physical Medicine and Rehabilitation", "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: K (Miskeyed). Verdict on keyed answer: Miskeyed. The stem describes established heterotopic ossification (HO) causing pain and limited abduction. The question asks for the 'most effective intervention to preserve joint mobility.' For established, symptomatic HO impairing mobility, the definitive treatment to restore motion is surgical excision once the lesion is mature (typically after 12-18 months, confirmed by a quiescent bone scan). The keyed answer (B, low-dose radiation) is a prophylactic measure to prevent HO recurrence after surgery or in high-risk settings, not the primary intervention for existing, mobility-limiting HO. While indomethacin (D) is also prophylactic, and bisphosphonates (A) can slow mineralization, surgical excision (C) is the standard for restoring mobility in established, symptomatic cases. The stem lacks critical timing details (e.g., 'acute onset' or 'mature lesion') to definitively rule out surgery, but given the presentation of limited mobility, surgery is the most effective intervention. The item is medically accurate in describing radiation's role but misapplies it to the clinical scenario. Minimal fix: Change the stem to '...undergoes functional electrical stimulation therapy. To prevent heterotopic ossification, what is the most effective intervention?' and keep key B, OR keep the stem as is and change the key to C (Surgical excision) with a note about maturity.\",\n  \"logical_false_reason\": \"K\",\n  \"logical_validity\": false,\n  \"medical_accuracy_score\": \n  \"4\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict on keyed answer: Miskeyed. The stem describes established heterotopic ossification (HO) causing pain and limited abduction. The question asks for the 'most effective intervention to preserve joint mobility.' For established, symptomatic HO impairing mobility, the definitive treatment to restore motion is surgical excision once the lesion is mature (typically after 12-18 months, confirmed by a quiescent bone scan). The keyed answer (B, low-dose radiation) is a prophylactic measure to prevent HO recurrence after surgery or in high-risk settings, not the primary intervention for existing, mobility-limiting HO. While indomethacin (D) is also prophylactic, and bisphosphonates (A) can slow mineralization, surgical excision (C) is the standard for restoring mobility in established, symptomatic cases. The stem lacks critical timing details (e.g., 'acute onset' or 'mature lesion') to definitively rule out surgery, but given the presentation of limited mobility, surgery is the most effective intervention. The item is medically accurate in describing radiation's role but misapplies it to the clinical scenario. Minimal fix: Change the stem to '...undergoes functional electrical stimulation therapy. To prevent heterotopic ossification, what is the most effective intervention?' and keep key B, OR keep the stem as is and change the key to C (Surgical excision) with a note about maturity.", "medical_accuracy_score": 4, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251225T204141396Z_grok-4-0709_seed132", "question_id": "20251225T204141396Z_grok-4-0709_seed132-004", "question": "A 67-year-old woman with a history of migraine presents with acute onset of hemianopia, ataxia, and confusion. CT angiography shows occlusion of the posterior inferior cerebellar artery with extension into the basilar artery. Despite thrombolysis, she deteriorates with locked-in syndrome. What rare complication is most likely responsible for this progression?", "options": ["Reperfusion injury", "Basilar artery dissection", "Paradoxical embolism", "Top-of-the-basilar syndrome", "Intracranial atherosclerotic disease"], "answer": "C", "answer_index": 2, "explanation": "Paradoxical embolism through a patent foramen ovale can cause extension of infarction in vertebrobasilar territory, leading to locked-in syndrome despite initial thrombolysis. Reperfusion injury typically manifests as hemorrhage, not progression of ischemia, while basilar artery dissection would show characteristic imaging findings not described. Top-of-the-basilar syndrome involves thalamic and midbrain infarction but lacks the cerebellar involvement here.", "generator_model": "grok-4-0709", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Neurology", "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: K (Miskeyed). Verdict: Miskeyed – a unique best answer exists but the provided key (C) is not it. Key stem clues: acute vertebrobasilar stroke (PICA occlusion extending into basilar artery) with deterioration to locked-in syndrome despite thrombolysis. The most likely complication explaining progression of ischemia after thrombolysis in this large-vessel occlusion is reperfusion injury (A), which includes failure of recanalization or reocclusion, not just hemorrhage. Paradoxical embolism (C) is an etiology of the initial stroke, not a complication of its progression post-thrombolysis. The item's logic incorrectly conflates stroke mechanism with treatment complication. Minimal fix: Change the key to A (Reperfusion injury) and adjust the rationale to explain reocclusion or no-reflow as mechanisms of clinical worsening.\",\n  \"medical_accuracy_score\":  \"3\",\n  \"logical_validity\": false,\n  \"logical_false_reason\": \"K\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict: Miskeyed – a unique best answer exists but the provided key (C) is not it. Key stem clues: acute vertebrobasilar stroke (PICA occlusion extending into basilar artery) with deterioration to locked-in syndrome despite thrombolysis. The most likely complication explaining progression of ischemia after thrombolysis in this large-vessel occlusion is reperfusion injury (A), which includes failure of recanalization or reocclusion, not just hemorrhage. Paradoxical embolism (C) is an etiology of the initial stroke, not a complication of its progression post-thrombolysis. The item's logic incorrectly conflates stroke mechanism with treatment complication. Minimal fix: Change the key to A (Reperfusion injury) and adjust the rationale to explain reocclusion or no-reflow as mechanisms of clinical worsening.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251225T204141396Z_grok-4-0709_seed132", "question_id": "20251225T204141396Z_grok-4-0709_seed132-005", "question": "A 28-year-old man presents with erythematous plaques on the trunk and extremities that worsen with sun exposure. Biopsy reveals interface dermatitis with vacuolar degeneration and apoptotic keratinocytes. Serology shows positive anti-Ro/SSA antibodies. Despite hydroxychloroquine, lesions persist. What is the most appropriate adjunctive therapy?", "options": ["Thalidomide", "Mycophenolate mofetil", "Intravenous immunoglobulin", "Lenalidomide", "Apremilast"], "answer": "A", "answer_index": 0, "explanation": "This is subacute cutaneous lupus erythematosus, and thalidomide is effective for refractory cases with photosensitivity and anti-Ro positivity due to its anti-angiogenic and immunomodulatory effects. Mycophenolate mofetil is more suited for systemic lupus but less effective for cutaneous-limited disease. Intravenous immunoglobulin is reserved for severe systemic involvement, not primarily cutaneous manifestations.", "generator_model": "grok-4-0709", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Dermatology", "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: K (Miskeyed). Verdict on keyed answer: Miskeyed. Key stem clues: subacute cutaneous lupus erythematosus (SCLE) with interface dermatitis, anti-Ro positivity, photosensitivity, hydroxychloroquine failure. The vignette describes classic SCLE. For refractory cutaneous lupus, current dermatology guidelines and standard board resources (e.g., UpToDate, Fitzpatrick's Dermatology) list antimalarials as first-line, then methotrexate, mycophenolate mofetil, or oral retinoids as second-line options. Thalidomide is a historical option with severe teratogenicity and neuropathy risks, now largely supplanted by safer agents; lenalidomide is not standard. Mycophenolate mofetil (B) is a well-established, evidence-based, and safer second-line therapy for refractory cutaneous lupus, including SCLE. The provided key (A) is outdated and not the current best answer. Main logical issue: key mismatch. Main medical accuracy issue: recommending a high-risk, teratogenic drug over safer, guideline-supported alternatives. Minimal fix: Change correct answer key to B (Mycophenolate mofetil) and update rationale to reflect current standard of care.\", \"logical_false_reason\": \"K\", \"logical_validity\": false, \"medical_accuracy_score\":", "judge_output_valid": false, "judge_parse_error": "json decode error: Expecting value: line 1 column 1250 (char 1249)"}, {"quiz_id": "20251225T204141396Z_grok-4-0709_seed132", "question_id": "20251225T204141396Z_grok-4-0709_seed132-006", "question": "A 42-year-old woman with rheumatoid arthritis and secondary fibromyalgia undergoes multidisciplinary pain management. She reports persistent widespread pain despite optimized pharmacotherapy. Quantitative sensory testing shows central sensitization. What advanced rehabilitation technique is most likely to provide long-term benefit?", "options": ["Graded motor imagery", "Transcutaneous electrical nerve stimulation", "Aquatic therapy", "Cognitive behavioral therapy alone", "Spinal cord stimulation"], "answer": "A", "answer_index": 0, "explanation": "Graded motor imagery effectively addresses central sensitization in fibromyalgia by reprogramming cortical representations, leading to sustained pain reduction in rheumatoid arthritis overlap. Transcutaneous electrical nerve stimulation provides short-term relief but does not target central mechanisms. Spinal cord stimulation is invasive and indicated for neuropathic pain, not widespread fibromyalgia pain.", "generator_model": "grok-4-0709", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Physical Medicine and Rehabilitation", "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: K (Miskeyed). Verdict on keyed answer: Miskeyed. Key stem clues: Rheumatoid arthritis with secondary fibromyalgia, persistent widespread pain despite optimized pharmacotherapy, quantitative sensory testing shows central sensitization. The question asks for the advanced rehabilitation technique most likely to provide long-term benefit. The keyed answer (A, Graded motor imagery) is a plausible technique for central sensitization, but the most evidence-based, guideline-recommended, first-line non-pharmacological intervention for fibromyalgia with central sensitization is cognitive behavioral therapy (CBT), often combined with exercise. While graded motor imagery has emerging evidence, CBT is the established cornerstone for long-term management. Option D is 'Cognitive behavioral therapy alone,' which is a standard, effective approach. The item's rationale dismisses CBT without justification, creating a miskey. The stem does not specify failure of CBT, making D defensible. Main logical issue: Key mismatch with best-supported answer. Main medical accuracy issue: Overlooking CBT as first-line for fibromyalgia central sensitization. Minimal fix: Change key to D, or modify stem to state 'despite optimized pharmacotherapy and cognitive behavioral therapy' to justify a more advanced technique like graded motor imagery.\", \"logical_false_reason\": \"K\", \"logical_validity\": false, \"medical_accuracy_score\": \t\"3\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict on keyed answer: Miskeyed. Key stem clues: Rheumatoid arthritis with secondary fibromyalgia, persistent widespread pain despite optimized pharmacotherapy, quantitative sensory testing shows central sensitization. The question asks for the advanced rehabilitation technique most likely to provide long-term benefit. The keyed answer (A, Graded motor imagery) is a plausible technique for central sensitization, but the most evidence-based, guideline-recommended, first-line non-pharmacological intervention for fibromyalgia with central sensitization is cognitive behavioral therapy (CBT), often combined with exercise. While graded motor imagery has emerging evidence, CBT is the established cornerstone for long-term management. Option D is 'Cognitive behavioral therapy alone,' which is a standard, effective approach. The item's rationale dismisses CBT without justification, creating a miskey. The stem does not specify failure of CBT, making D defensible. Main logical issue: Key mismatch with best-supported answer. Main medical accuracy issue: Overlooking CBT as first-line for fibromyalgia central sensitization. Minimal fix: Change key to D, or modify stem to state 'despite optimized pharmacotherapy and cognitive behavioral therapy' to justify a more advanced technique like graded motor imagery.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 3}]